Abstract
Introduction
Indefinite proton pump inhibitor (PPI) therapy and endoscopic evaluation for Barrett’s esophagus is recommended for erosive esophagitis (EE). However, the clinical course of EE remains undefined.
Methods
Adults with EE on esophagogastroduodenoscopy (EGD) were identified at Mayo Clinic Rochester between January 2003 and September 2005. Patients with repeat EGD performed after index endoscopy were included. Patients with a history of upper gastrointestinal surgery, esophageal cancer, achalasia, or Barrett’s on initial EGD were excluded.
Results
Of 219 patients identified, 98 had LA grade A, 72 LA grade B, and 49 LA grade C esophagitis. Persistent EE was found in 27% on repeat endoscopy. No patients progressed to more severe grades of esophagitis. While discontinuation of PPI was associated with persistent esophagitis, long-term healing of esophagitis occurred in the majority of patients despite discontinuation of PPI. Grade A or B esophagitis and the absence of hiatal hernia were also independent predictors of esophagitis healing on multivariate analysis. The rate of Barrett’s esophagus was similar among patients with LA grade A/B and C esophagitis on initial EGD (5% vs. 14%, p = 0.6).
Conclusion
The majority of patients with EE demonstrated healing at follow-up endoscopy regardless of continued PPI use. A small proportion developed Barrett’s esophagus, including those with LA grade A and B esophagitis, highlighting a potential role for repeat endoscopy in all grades of EE. A more conservative long-term PPI strategy may be reasonable in patients with LA grade A or B esophagitis in the absence of hiatal hernia.
Similar content being viewed by others
References
Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018;154:267–276.
Hanna S, Rastogi A, Weston AP, Totta F, et al. Detection of Barrett’s esophagus after endoscopic healing of erosive esophagitis. Am J Gastroenterol. 2006;101:1416–1420.
Savarino E, de Bortoli N, De Cassan C, Della Coletta M, et al. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1–9.
Khan Z, Alastal Y, Khan MA, Khan MS, et al. On-demand therapy with proton pump inhibitors for maintenance treatment of nonerosive reflux disease or mild erosive esophagitis: a systemic review and meta-analysis. Gastroenterol Res Pract. 2018;12:6417526.
Pace F, Tonini M, Pallotta S, Molteni P, Porro GB. Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken ‘on-demand’. Aliment Pharmacol Ther. 2007;26:195–204.
Mochizuki N, Fujita T, Kobayashi M, Yamazaki Y, et al. Factors associated with the presentation of erosive esophagitis symptoms in health checkup subjects: a prospective, multicenter cohort study. PLoS ONE. 2018;13:e0196848.
Westhoff B, Brotze S, Weston A, McElhinney C, et al. The frequency of Barrett’s esophagus in high-risk population with chronic GERD. Gastrointest Endoc. 2005;61:226–231.
ASGE Standards of Practice Committee, Muthusamy VR, Lightdale JR, Acosta RD, et al. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81:1305–1310.
Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, et al. Erosive esophagitis is a risk factor for Barrett’s esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol. 2011;106:1952–1964.
Jung SH, Oh JH, Kang SG. Clinical characteristics and natural history of asymptomatic erosive esophagitis. Turk J Gastroenterol. 2014;25:248–252.
Malfertheiner P, Nocon M, Vieth M, Stolte M, et al. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care-the ProGERD study. Aliment Pharmacol Ther. 2012;35:154–164.
Manabe N, Yoshihara M, Sasaki A, Tanaka S, et al. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol. 2002;17:949–954.
Labenz J, Nocon M, Lind T, et al. Prospective follow up data from the ProGERD study suggest that GERD is not a categorical disease. Am J Gastroenterol. 2006;101:2457–2462.
Metz DC, Pilmer BL, Han C, et al. Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data. Am J Gastroenterol. 2011;106:1953–1960.
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.
El-Serag H. The association between obesity and GERD: a review of epidemiological evidence. Dig Dis Sci. 2008;53:2307–2312.
El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett’s esophagus. Am J Gastroenterol. 2005;100:2151–2215.
Camilleri M, Malhi H, Acosta A. Gastrointestinal complication of obesity. Gastroenterology. 2017;15:1656–1670.
Kamat P, Wen S, Morris J, Anandasabapathy S. Exploring the association between elevated body mass index and Barrett’s esophagus: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87:655–662.
Corley DA, Kubo A, Levin TR, Block G, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology. 2007;133:34–41.
Lee SW, Lien HC, Lee TY, Tung CF, et al. Impact of obesity on a Chinese population with erosive esophagitis and Barrett’s esophagus. Gut Liver. 2017;11:377–382.
Singh S, Sharma AN, Murad MH, Buttar NS, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1399–1412.
Schlottmann F, Andolfi C, Herbella FA, Rebecchi F, et al. GERD: presence and size of hiatal hernia influence clinical presentation, esophageal function, reflux profile, and degree of mucosal injury. Am Surg. 2018;84:978–982.
Andrici J, Tio M, Cox MR, Eslick GD. Hiatal hernia and the risk of Barrett’s esophagus. J Gastroenterol Hepatol. 2013;28:415–431.
Faas R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41:131–137.
Faas R, Ofmann JJ. Gastroesophageal reflux disease-should we adopt a new conceptual framework? Am J Gastroenterol. 2002;97:1901–1909.
Katz PO, Gerson LB, Vela MF. Guidelines for diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328.
Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, et al. Predictors for squamous re-epithelialization of Barrett’s esophagus after endoscopic biopsy. J Gastroenterol Hepatol. 2007;22:901–907.
Author information
Authors and Affiliations
Contributions
Dr. Bi (Bi.Danse@mayo.edu) is a resident in the department of Internal Medicine at the Mayo Clinic Rochester. She was instrumental in the collection and analysis of the data and writing of the manuscript. Dr. Katzka (Katzka.David@mayo.edu) is a gastroenterologist in the department of Gastroenterology and Hepatology at the Mayo Clinic Rochester. He assisted in the conduct of the study and drafting of the manuscript. Crystal Lavey (Lavey.Crystal@mayo.edu) is a research assistant in the department of Gastroenterology and Hepatology at the Mayo Clinic Rochester. She assisted in the collection of the data. Dr. Ravi (Ravi.Karthik@mayo.edu) is a gastroenterologist in the department of Gastroenterology and Hepatology at the Mayo Clinic Rochester. He was instrumental in the design and conduct of the study, the collection and analysis of the data, and writing of the manuscript. None of the authors has any financial disclosures and all approve the final manuscript for submission.
Corresponding author
Ethics declarations
Conflict of interest
The author declares that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bi, D., Katzka, D.A., Lavey, C.J. et al. Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients. Dig Dis Sci 65, 3244–3252 (2020). https://doi.org/10.1007/s10620-019-06027-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-06027-1